Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002383555 | SCV002697602 | uncertain significance | Cardiovascular phenotype | 2018-10-24 | criteria provided, single submitter | clinical testing | The p.T455R variant (also known as c.1364C>G), located in coding exon 7 of the TTN gene, results from a C to G substitution at nucleotide position 1364. The threonine at codon 455 is replaced by arginine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species, and arginine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003138242 | SCV003819029 | uncertain significance | not provided | 2019-05-24 | criteria provided, single submitter | clinical testing |